Market Closed -
Other stock markets
|
Pre-market 07:35:04 am | |||
75.42 USD | +1.49% | 75.7 | +0.37% |
Apr. 25 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Apr. 24 | Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 8.32B |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -172M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-67.4
x | P/E ratio 2025 * |
-48.7
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.97% |
Latest transcript on Viking Therapeutics, Inc.
1 day | +1.49% | ||
1 week | +18.12% | ||
Current month | -8.02% | ||
1 month | -8.02% | ||
3 months | +215.43% | ||
6 months | +716.23% | ||
Current year | +305.27% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 75.42 | +1.49% | 2,827,859 |
24-04-26 | 74.31 | +7.91% | 3,535,445 |
24-04-25 | 68.86 | +5.82% | 3,526,931 |
24-04-24 | 65.07 | +0.22% | 2,584,595 |
24-04-23 | 64.93 | +1.69% | 2,032,588 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+305.27% | 8.32B | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.80% | 22.18B | |
-16.67% | 21.2B | |
-8.68% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- VKTX Stock